This brand name is authorized in Nigeria.
The drug NEURACALM contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
55JG375S6M - PREGABALIN
|
|
Pregabalin binds to an auxiliary subunit (α2-δ protein) of voltage-gated calcium channels in the central nervous system. |
|
2
|
UNII
BR1SN1JS2W - METHYLCOBALAMIN
|
|
Hydroxocobalamin is used in the treatment and prevention of Vitamin B12 deficiency. For adults, the daily requirement of Vitamin B12 is probably about 1 to 2 micrograms and this amount is present in most normal diets. However, Vitamin B12 only occurs in animal products, not in vegetables, and therefore strict vegetarian or vegan diets that exclude dairy products may provide an inadequate amount, although a deficiency may not be apparent for many years. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-0462 | Capsule | Neuracalm 75 Capsule CAP 75 mg; 750 mcg 3 x 10's (in Alu-Alu pack) | Hard Gelatin Capsule | 24/06/2021 |
| B4-1463 | Capsule | Neuracalm 150 Capsule (Check Strength) CAP 150 mg; 750 mg 3 x 10's (in Alu-Alu pack) | Capsule | 24/06/2021 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| N02BF02 | Pregabalin | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BF Gabapentinoids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-0462, B4-1463 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.